Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FVKR9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,248
Award facts
- Contract value 100% obligated
- $17,247.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,247.65 delivery order to AmerisourceBergen Drug Corp for Aimovig 140 mg/ml autoinjectors on September 8, 2025, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Aimovig is a monoclonal antibody used for migraine prevention, representing a specialized pharmaceutical product within AmerisourceBergen's extensive federal medical supply portfolio.
This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent contract, designated as SPE2DX, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs and other federal healthcare systems worldwide. The company's demonstrated capability to fulfill federal procurement requirements through open competition and its significant role in supporting Defense Health Agency and other government healthcare customers underscore its position as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FVKR9?
SPE2DB25FVKR9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FVKR9 worth?
The government has obligated $17,248 on SPE2DB25FVKR9.
Is contract SPE2DB25FVKR9 an order under another contract?
Yes. SPE2DB25FVKR9 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVKR9 competed?
The extent of competition for SPE2DB25FVKR9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award